Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
top of page
Search
- May 2, 2021
- 4 min
Recce Pharmaceuticals Limited – A revolution in development of treating superbugs
Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...
196 views0 comments
- Jan 8, 2021
- 2 min
Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
975 views0 comments
- Dec 30, 2020
- 5 min
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
3,758 views0 comments
- Dec 9, 2020
- 3 min
Ionis Pharmaceuticals - A force for life
RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...
477 views0 comments
- Nov 26, 2020
- 2 min
Antisense Therapeutics Limited dual-lists in Europe
An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...
117 views0 comments
bottom of page